QuidelOrtho
Update in progressQDEL (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
QuidelOrtho Corporation delivers diagnostic testing solutions through four units: Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics. Labs provides clinical chemistry and immunoassay instruments and tests to evaluate health, monitor disease, and assess organ function; Transfusion Medicine offers immunohematology and donor screening tools for blood typing and infectious disease screening; Point of Care delivers rapid, on-site tests; Molecular Diagnostics offers PCR systems and sample-to-result assays for infectious diseases. The company sells directly and through distributors worldwide. Founded 1979; headquartered in San Diego, California.
Company score
- Sentiment
- 0.26
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.48
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.22
- Governance
- 0.12
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.25
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.26
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEOMr. Brian J. Blaser
- Founded1979
- Employees6,500
- Websitewww.quidelortho.com